Peer-reviewedCC BY 4.0Frontiers in Immunology
Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities
5 affiliations
- 1Laboratorio de Investigaciones Bioquímicas de la Facultad de Medicina (LIBIM), Instituto de Química Básica y Aplicada del Nordeste Argentino (IQUIBA-NEA), Universidad Nacional del Nordeste, Consejo Nacional de Investigaciones Científicas y Técnicas (UNNE-CONICET)
- 2CONICET-Universidad Nacional de Luján, Instituto de Ecología y Desarrollo Sustentable (INEDES), Grupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB)
- 3Universidad Nacional de Lujan, Departamento de Ciencias Básicas, Laboratorio de Inmunología
- 4Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas UVa
- 5Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III
Related
- Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
- Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities
- Editorial: Unlocking the potential of extracellular vesicles in tumor immunity and drug resistance
- Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications
- Editorial: The role of RNA regulation in cancer pathogenesis and therapeutic strategies
BibTeX
@article{rodriguez2026editorial,
title = {{Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities}},
author = {Juan Pablo Rodríguez and Mauricio César De Marzi and Jesús Balsinde},
journal = {Frontiers in Immunology},
year = {2026},
month = sep,
doi = {10.3389/fimmu.2026.1992695},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1992695/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities
AU - Juan Pablo Rodríguez
AU - Mauricio César De Marzi
AU - Jesús Balsinde
PY - 2026
DA - 2026/09/30
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1992695
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1992695/full
SN - 1664-3224
ER -